ANIP - Ani Pharmaceuticals Inc

Insider Sale by Cook Meredith (SVP, GC, SEC.)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

Yesterday, Cook Meredith, serving as SVP, GC, SEC. at Ani Pharmaceuticals Inc (ANIP), sold 500 shares at $77.95 per share, for a total transaction value of $38,975.00. Following this transaction, Cook Meredith now holds 78,890 shares of ANIP.

This sale represents a 1.00% decrease in Cook Meredith's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, April 13, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 13, 2026, meaning the disclosure happened on the same day as the trade.

Ani Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Cook Meredith

SVP, GC, SEC.

Meredith W. Cook is Senior Vice President, General Counsel, and Corporate Secretary at ANI Pharmaceuticals, a position she has held since July 18, 2022[[1]](https://fintool.com/app/research/companies/ANIP/people/meredith-cook)[[2]](https://drugstorenews.com/ani-appoints-new-legal-executive). With over 20 years of legal and leadership experience in specialty and generic pharmaceuticals, Cook brings substantial expertise in corporate governance, mergers and acquisitions, strategic transactions, and intellectual property[[2]](https://drugstorenews.com/ani-appoints-new-legal-executive). She earned her bachelor's degree in East Asian Studies from Princeton University and her Juris Doctor from Tulane Law School[[2]](https://drugstorenews.com/ani-appoints-new-legal-executive). Prior to joining ANI, Cook held senior legal roles at Amneal Pharmaceuticals, where she served as Vice President and Associate General Counsel overseeing corporate and strategic transactions across business units, and at Dr. Reddy's Laboratories, where she was Global Legal Head for M&A, business development, and strategic transactions[[1]](https://fintool.com/app/research/companies/ANIP/people/meredith-cook)[[2]](https://drugstorenews.com/ani-appoints-new-legal-executive). She began her legal career at major firms Morgan Lewis & Bockius and Vinson & Elkins[[1]](https://fintool.com/app/research/companies/ANIP/people/meredith-cook)[[2]](https://drugstorenews.com/ani-appoints-new-legal-executive). At ANI, Cook has played a key role in significant corporate initiatives, including M&A diligence, deal execution and integration of the Alimera acquisition, and leadership on litigation and intellectual property matters[[1]](https://fintool.com/app/research/companies/ANIP/people/meredith-cook).

View full insider profile →

Trade Price

$77.95

Quantity

500

Total Value

$38,975.00

Shares Owned

78,890

Trade Date

Monday, April 13, 2026

1 days ago

SEC Filing Date

Monday, April 13, 2026

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Ani Pharmaceuticals Inc

Company Overview

No company information available
View news mentioning ANIP

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5613076

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime